Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;45(2):163-172.
doi: 10.1080/10790268.2020.1730109. Epub 2020 Mar 17.

Non-opioid pharmacologic treatment of chronic spinal cord injury-related pain

Affiliations
Review

Non-opioid pharmacologic treatment of chronic spinal cord injury-related pain

Mendel Kupfer et al. J Spinal Cord Med. 2022 Mar.

Abstract

Purpose: Spinal cord injury-related pain is often a severe debilitating condition that adversely affects the patient's physical health, psychological wellbeing and quality of life. Opioid medications have historically been prescribed to this population with great frequency. As opioid abuse disorder becomes an ever-worsening public health issue, more attention must be placed upon non-opioid options. This paper reviews non-opioid medications to be considered when treating spinal cord injury-related pain. The pertinent literature is reviewed, and the advantages and pitfalls of various medication options are discussed in the complicated context of the individual with a spinal cord injury.Methods: Peer-reviewed journal articles and medication package insert data are reviewed.Results:. The non-opioid medications with the greatest evidence for efficacy in the treatment of chronic spinal cord injury-related pain are drawn from the antiepileptic drug and antidepressant categories though the specific selection must be nuanced to the particular individual patient. More research is required to understand the role of calcitonin, lithium, and marijuana in treating spinal cord injury-related pain.Conclusions: The complex clinical situation of each individual patient must be weighed against the risks and benefits of each medication, as reviewed in this paper, to determine the ideal treatment strategy for chronic spinal cord injury-related pain.

Keywords: Chronic pain; Gabapentin; Neuropathic pain; Pharmacology; Spinal cord injury; Substance-related disorders.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Siddall PJ, Loeser JD.. Pain following spinal cord injury. Spinal Cord 2001;39:63–73. - PubMed
    1. Siddall PJ, McClelland JM, Rutkowski SB, Cousins MJ.. A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain 2003;103:249–257. - PubMed
    1. Burke D, Fullen BM, Stokes D, Lennon O.. Neuropathic pain prevalence following spinal cord injury: a systematic review and meta-analysis. Eur J Pain 2017;21:29–44. - PubMed
    1. Dijkers M, Bryce T, Zanca J.. Prevalence of chronic pain after traumatic spinal cord injury: a systematic review. J Rehabil Res Dev 2009;46:13. - PubMed
    1. Werhagen L, Budh CN, Hultling C, Molander C.. Neuropathic pain after traumatic spinal cord injury – relations to gender, spinal level, completeness, and age at the time of injury. Spinal Cord 2004;42:665–673. - PubMed

MeSH terms